Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysis. [PDF]
Pidala J+23 more
europepmc +1 more source
Lactobacillus gasseri prevents ibrutinib-associated atrial fibrillation through butyrate. [PDF]
Shi L+13 more
europepmc +1 more source
Computational molecular insights into ibrutinib as a potent inhibitor of HER2-L755S mutant in breast cancer: gene expression studies, virtual screening, docking, and molecular dynamics analysis. [PDF]
Loganathan T, George Priya Doss C.
europepmc +1 more source
Oncoral Follow-Up for Outpatients Treated with Oral Anticancer Drugs Assessed by Relative Dose Intensity. [PDF]
Larbre V+13 more
europepmc +1 more source
Correction: Ibrutinib, a Bruton's tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma. [PDF]
Wang J+7 more
europepmc +1 more source
Inhibition of Putative Ibrutinib Targets Promotes Atrial Fibrillation, Conduction Blocks, and Proarrhythmic Electrocardiogram Indices: A Mendelian Randomization Analysis. [PDF]
Xu H+8 more
europepmc +1 more source
Transcriptomic profiling in canine B-cell lymphoma supports a synergistic effect of BTK and PI3K inhibitors. [PDF]
Lainscsek X+7 more
europepmc +1 more source
Greek Consensus on Chronic Lymphocytic Leukemia (CLL) Treatment. [PDF]
Sachanas S+7 more
europepmc +1 more source
Diagnosis and treatment of chronic lymphocytic leukemia: 2025 recommendations of the Brazilian Group of Chronic Lymphocytic Leukemia of the Brazilian Association of Hematology and Hemotherapy (ABHH). [PDF]
Chiattone CS+22 more
europepmc +1 more source
Functional proteoform group deconvolution reveals a broader spectrum of ibrutinib off-targets. [PDF]
Leo IR+6 more
europepmc +1 more source